Fransman Wouter, Vermeulen Roel, Kromhout Hans
Environmental and Occupational Health Division, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.
Int Arch Occup Environ Health. 2005 Jun;78(5):403-12. doi: 10.1007/s00420-004-0595-1. Epub 2005 May 11.
To determine levels of potential and actual dermal exposure to cyclophosphamide (CP) during performance of oncology-related tasks in hospitals and to investigate the relationship with potential sources and surface contamination levels of CP.
Dermal exposure to CP was determined for tasks with potential exposure to CP: preparation of CP, decanting of patients' urine, washing of the patient, removal of bed sheets of treated patients and cleaning of patients' toilets on oncology wards. Exposure was assessed by the collection of nitrile and latex protective medical gloves (potential exposure), washing of hands (actual exposure), from cotton pads attached to (un)covered forearms (potential or actual exposure) and a wipe sample of the forehead (actual exposure). Bulk samples (i.e. application fluids and patients' excreta) and possible contact surfaces were monitored to assess the amount of CP available for dermal exposure.
Pharmacy technicians, oncology nurses and cleaning personnel showed actual and potential dermal exposure to CP during performance of their daily duties. Exposure occurred predominantly on the hands and sporadically on the forehead and forearms. Although all nurses used gloves during handling of patients' urine and sometimes during the other nursing tasks, skin underneath gloves was repeatedly contaminated. Results of tests on bulk and surface contamination samples confirmed that patients intravenously treated with CP excrete the unmetabolised drug, which could subsequently lead to dermal exposure of hospital personnel. A clear relationship was found between dermal exposure levels and direct sources of exposure for all tasks, except for handling patients' urine.
We demonstrated for the first time that actual dermal exposure to CP is common among oncology nurses working with patients treated with this anti-neoplastic drug. Pharmacy technicians and cleaning personnel, on the other hand, are potentially exposed to CP, and protection provided by gloves seemed to be sufficient.
确定医院肿瘤相关工作中接触环磷酰胺(CP)的潜在和实际皮肤暴露水平,并调查其与CP潜在来源和表面污染水平的关系。
对有潜在CP暴露风险的工作进行皮肤暴露测定,包括:CP配制、倾倒患者尿液、为患者洗澡、更换接受治疗患者的床单以及清洁肿瘤病房患者的卫生间。通过收集腈类和乳胶防护医用手套(潜在暴露)、洗手(实际暴露)、从前臂(有或无覆盖物)附着的棉垫上收集(潜在或实际暴露)以及擦拭额头样本(实际暴露)来评估暴露情况。对大量样本(即应用液和患者排泄物)以及可能的接触表面进行监测,以评估可供皮肤接触的CP量。
药剂师、肿瘤护士和清洁人员在日常工作中均显示出对CP的实际和潜在皮肤暴露。暴露主要发生在手部,偶尔也出现在额头和前臂。尽管所有护士在处理患者尿液时以及有时在其他护理工作中都使用了手套,但手套下的皮肤仍反复受到污染。大量样本和表面污染样本的检测结果证实,接受CP静脉治疗的患者会排泄未代谢的药物,这可能导致医院工作人员的皮肤暴露。除处理患者尿液外,所有工作的皮肤暴露水平与直接暴露源之间均存在明显关联。
我们首次证明,在护理接受这种抗肿瘤药物治疗患者的肿瘤护士中,实际皮肤接触CP的情况很常见。另一方面,药剂师和清洁人员有潜在接触CP的风险,手套提供的防护似乎足够。